Welcome to EpilepsyU.com a social network dedicated to the epilepsy community

Share This Post

Autism / Education / Epilepsy / Global / Media / Medicine / Migraine / Neurology / News / Technology / Treatment / VNS / Women and Epilepsy

Noninvasive VNS Device Proves Itself Safe and Effective

Noninvasive VNS Device Proves Itself Safe and Effective

electrocore_website_gammaCore_section_banner_560pxNon-invasive vagus nerve stimulation (nVNS) ‘improves the safety and tolerability of VNS making it more accessible and facilitating further investigations across a wide range of uses when compared with surgically implanted VNS’ according to a review in the European Journal of Neurology. The review then went on to look at the efficacy of both surgically implanted VNS and non-invasive VNS including electroCore’s gammaCore device.

Professor Stephen Silberstein of Thomas Jefferson University – one of the authors of the paper – commented:

This review confirms that nVNS is safe and effective and because there is no surgery involved and because the costs are very competitive we believe it could open up a whole variety of conditions which we have responded to vagus nerve stimulation.

The Cyberonics VNS implant which has a licence in North America and Europe for refractory epilepsy and depression has been implanted in more than 70,000 patients over the last twenty years and has been found to be helpful to patients with several other conditions including headache, anxiety, gastric obesity and other conditions. However because of the high cost of treatment and the involvement of a surgical procedure these conditions were never researched in depth or brought to market.

JP Errico, CEO and founder of electroCore, commented:

This paper again validates how safe and effective VNS therapy is. It also shows how our gammaCore device can eliminate the surgical side effects and still provide effective stimulation. Our extensive pre-clinical and clinical program is already demonstrating how effective this treatment is across a variety of conditions.

electroCore has developed non-invasive Vagus Nerve Stimulation (nVNS) self-administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields. The company’s initial focus is on the treatment of primary headaches (migraine and cluster headache), and the associated chronic co-morbidities of gastric motility, psychiatric, sleep, and pain disorders that drive disproportionately large direct and indirect costs within the healthcare system and society.

Share This Post

2 Comments

  1. I didn’t know there was a non invasive vns

  2. I didn’t know about this device before I had my VNS implant. I have responded well to the implant and am pleased with that however, I would prefer an external device. I am aware of the T- VNS and hope it passes the clinical trials here in the US. As soon as doctors can prescribe these options, I will not hesitate to have the implant removed providing they give the same level of seizure control. External just makes sense providing the individual is capable of following the guidelines to using and administering the treatments as directed. If Cyberonics wants to remain in the game I would recommend they get on board with pursuing this option because watchful eyes are keeping track of new innovations. I would have really liked to have been able to give such products before I had to go through surgery and later deal with the bothersome issues that come with an implanted device.

Comments are now closed for this post.